Vaccine vial with syringe

FDA expert panel endorses idea of removing a component from flu vaccine

Arnold Monto quoted in Stat

The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline.

Maize and blue graphic of a vaccine.

Exploring the cost-effectiveness of RSV vaccines in older adults

Q&A with David Hutton

David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).